OBJECTIVE: To determine if obesity measures are related to measures of low-density lipoprotein (LDL) size and LDL subfractions in a population of Mexican-Americans with high prevalence of obesity. METHODS: LDL size phenotypes, based on nondenaturing gradient gel electrophoresis and staining for cholesterol (using Sudan black B), were determined for 313 unrelated Mexican-American participants in the San Antonio Family Heart Study. LDL size measures included predominant particle diameter, median diameter (particle diameter, where half the LDL absorbance is on larger and half on smaller LDLs) and cholesterol level in various LDL subfractions. Adiposity traits included two measures of general body fatness (body-mass index (BMI) and fat mass determined with bioimpedance) and three measures of regional fat deposition (waist-to-hip ratio (WHR), waist circumference and subscapular-triceps skinfold ratio (STR)). RESULTS: Gender and diabetes were signi®cantly associated with most LDL size measures. In addition, BMI, WHR, waist circumference and STR were signi®cantly (P`0.05) associated with several LDL size measures. Stepwise regression analysis (including adjustment for age, gender and diabetes status) showed that in every case, the strongest adiposity correlate of LDL size, was WHR, which re¯ects deposition of visceral fat. If triglyceride (TG) concentration was also included in the models, no fat measure was independently correlated with LDL size, suggesting that elevation of TG, associated with increased adiposity, was more directly correlated with LDL size. Supporting this interpretation, we found that WHR was also the strongest correlate of TG among adiposity measures. Regression analysis of the LDL particle size cholesterol pro®le expressed in 0.1 nm increments revealed a positive correlation of WHR and LDLs in the interval 25.9 ± 26.3 nm (P`0.05) and a negative correlation of BMI with LDLs in the interval 27.3 ± 28.1 nm (P`0.05). CONCLUSION: These results suggest that different adiposity measures, re¯ecting different aspects of fat deposition, are related to speci®c LDL size intervals. We speculate that increased deposition of fat, particularly visceral fat, is associated with increased TG, which in turn is associated with decreases in LDL particle size.
Introduction
Small dense low-density lipoprotein (LDL) particles are a well-established component of the atherogenic lipoprotein phenotype, 1 in which a number of dyslipidaemias, such as low high density-lipoprotein (HDL) cholesterol and high triglyceride (T-G) concentrations, appear to cluster in individuals. Results from several prospective studies indicate LDL size variation predicts risk of cardiovascular disease (CVD). 2 ± 4 Furthermore, change in LDL size (density) was the strongest predictor of coronary stenosis change in the Familial Atherosclerosis Treatment Study. 5 Obesity is also related to CVD and to dyslipidaemia, 6 ± 12 but the metabolic determinants that link obesity and dyslipidaemia are not well understood. Small dense LDLs have been associated with obesity in several studies. Terry et al 13 found that the waist-to-hip ratio (WHR) was strongly associated with dense LDLs (S f 0-7), and a number of studies have reported associations of obesity with LDL peak diameters andaor LDL size distribution patterns, determined by use of gradient gel electrophoresis. 12,14 ± 18 Moreover, LDL size phenotypes were signi®cantly associated with visceral adiposity, as estimated by WHR 14 ± 17 and also as directly measured by computed tomography. 18 In some of these studies, 16, 17 WHR was more strongly associated with LDL size phenotype than was body-mass index (BMI), a global measure of adiposity. These results suggest that regional patterns of fat deposition might be differentially associated with dyslipidaemia and, perhaps, risk of CVD. In one recent study, 19 BMI was found to be signi®cantly associated with LDLs between 24.2 and 25.5 nm (that is, LDL-III), but other measures of adiposity were not evaluated in that study.
For the most part, the previous studies of the relationship between LDL and obesity measures have used samples from Caucasians. The goal of this study was to determine whether obesity measures are related to measures of LDL size in a population of Mexican-Americans, in whom the prevalence of obesity is high. 20 Also, we have tested the hypothesis that LDL size variation is more strongly associated with visceral fat (as indicated by WHR) rather than overall adiposity and we have determined the precise intervals of LDL particle size that are related to the adiposity measures.
Materials and methods

Subjects and blood samples
The San Antonio Family Heart Study is a study of risk factors for CVD in Mexican-Americans, living in and around San Antonio, Texas. 21 For the present analysis, a subset of unrelated individuals was selected on the basis of pedigree information (that is, they were not selected on the basis of phenotype). For the most part, the unrelated individuals consisted of married-in spouses and, consequently, they averaged about ten years older than the overall study population, which included younger family members. At a clinic visit, participants provided a fasting blood sample and a number of anthropometric measures were obtained. In addition, an oral glucose tolerance test was administered and diabetes status was determined using World Health Organization criteria. 22 Plasma was prepared by low-speed centrifugation and stored at À80 C in single-use aliquots contained in segments of plastic tubing, as described, 23 protected from oxidation and desiccation. Clinic procedures were reviewed by the Institutional Review Board for the University of Texas Health Science Center at San Antonio, and all subjects gave written informed consent.
Measurements of adiposity
We evaluated adiposity by use of several anthropometric measurements. BMI, calculated as weight divided by height squared (kgam 2 ), and fat mass (FM, kg), derived using bioimpedance analysis (Valhalla Scienti®c, San Diego, CA), were used as global measures of adiposity. In addition, we obtained three measures of body fat distribution. Waist and hip circumferences were measured using a steel tape measure and WHR was calculated as the ratio of these two measures. Waist circumference 24 and WHR were used as indices of visceral fat deposition. Skinfold thicknesses were measured with Lange calipers, each value representing the average of three measurements, and subscapular-triceps skinfold ratio (STR) was calculated as the ratio of the subscapular to triceps skinfold thicknesses. STR was used to indicate centrality of fat distribution. 25 Measurements of LDL size LDL particles in plasma were resolved using nondenaturing gradient gel electrophoresis and stained for cholesterol with Sudan black B as described. 26 Although Sudan black B binds neutral lipids in the test tube, 27 Callais et al concluded that HDL cholesterol quantitation was unaffected by TG concentration. 28 In addition, several studies have demonstrated that Sudan black B accurately re¯ects cholesterol distributions among sizeresolved lipoproteins 28 ± 30 and we have found this to be the case for LDL subfractions as well (DL Rainwater, unpublished observations). Size distributions of stain were determined using the LKB-Ultroscan XL laser densitometer running with GSXL software (Pharmacia, Piscataway, NJ). Absorbance pro®les were converted to ASCII ®les with GELCON (Pharmacia, Piscataway, NJ) and analyzed using software we developed which allows gel calibration and baseline subtraction 26, 31 ; calibrators included carboxylated polystyrene microspheres (38.0 nm, Duke Scienti®c), thyroglobulin (17.0 nm, Pharmacia, Piscataway, NJ), and two LDL bands in a lyophilized standard (27.5 nm and 26.6 nm). 26 Measured indicators of LDL size distributions included: LDL size (diameter of the predominant LDL peak), median diameter (the diameter where half the LDL absorbance is on larger particles and half on smaller particles), and fractional absorbance for four LDL subfractions 26, 32 (LDL-I, 26.4±29.0 nm; LDL-II, 25.5± 26.4 nm; LDL±III, 24.2-25.5 nm; and LDL-IV, 21.0± 24.2 nm). Fractional absorbance was calculated as absorbance in each subfraction divided by total LDL absorbance and was converted to concentration units by multiplication with LDL cholesterol (LDL-C) concentrations. LDL-C concentrations were calculated from non-HDL cholesterol and plasma TG concentrations, using a modi®cation of the Friedewald formula, which allows for use of samples with TG`8.0 mmolaL. 33, 34 Each sample was replicated on at least two different gels (mean was 2.1 runs per sample, s.d. was 0.4). We analyzed the mean value for each measurement with the exception that only one pro®le per sample was used to assess fractional absorbance at 0.1 nm increments. Based on repeated measures for 324 samples replicated across gels, repeatabilities for the LDL measurements were 92.9% for LDL diameter, 90.0% for median diameter, and 86.1%, 73.9%, 79.2% and 56.6% for absorbances in LDL-I, LDL-II, LDL-III and LDL-IV, respectively. For some studies we analyzed LDL absorbance pro®les that were cut into 60 fractions between 23 nm and 29 nm (that is, 0.1 nm increments of LDL size). Cholesterol concentrations in each fraction were estimated by multiplication with LDL-C.
Statistical methods
A commercial statistics package was used for all analyses (StatGraphics Plus, Manugistics, Rockville, MD). To reduce skewness, BMI and STR were log e -transformed; after this transformation, the LDL particle size and adiposity DL Rainwater et al distributions of these, as well as the other, anthropometric measurements were not signi®cantly different from normal (Kolmogorov-Smirnov test).
Results
Characteristics of the population
We identi®ed 313 participants in the SAFHS who were unrelated to each other and who were not taking lipid-lowering medications. The average age was 46 y (45 y for women and 47 y for men) and 60% were women. Table 1 . Compared to men, women had higher mean values for BMI and FM, but lower mean values for WHR and STR; there was no gender difference for waist circumference in this population. As expected, women also had more favorable lipid pro®les with lower TG, non-HDL cholesterol and apoB concentrations, and higher HDL cholesterol concentrations.
LDL particle size
We used nondenaturing gradient gel electrophoresis to assess the diameter of the predominant species of LDL for each sample. There appeared to be two major modalities for LDL size, one at about 25.5 nm and the other at about 26.8 nm. Figure 1A shows that there was a baseline separation between the two modalities of LDL particle size, with the nadir at about 26.2 nm. In this population, therefore, LDL particles less than 26.2 nm in diameter were considered`small'.
LDL size distributions
The distribution of cholesterol among LDLs was assessed using the absorbance pro®le of Sudan black B, which stains cholesterol among lipoproteins. Two classes of phenotypes were determined: median diameter (the diameter of particles splitting the LDL absorbance pro®le in half) and cholesterol concentrations in four LDL subfractions. Frequency histograms for these traits are given in Figure LDL particle size and adiposity DL Rainwater et al LDL-IV, respectively (each signi®cantly different from the other, P`0.0001).
Covariate effects on LDL size properties Several covariates were tested for possible effects on LDL size, and mean effects are given in Table 2 . Both gender and diabetes status were associated with strong and signi®cant effects on most of the LDL phenotype measures. Figure 2 shows frequency histograms for LDL size in nondiabetic (panel A) and diabetic (panel B) subjects according to gender. Men and diabetic subjects tended to have smaller LDL particles and this was also re¯ected in the measures of LDL size distribution (data not shown). Alcohol use and hypertension medication use were associated with modest effects on just a single LDL subfraction, LDL-IV (P 0.02) and LDL-II (P 0.03), respectively (Table 2) . However, when gender and diabetes status were included in the model, there were no signi®cant effects of these two covariates on any of the LDL size phenotypes. Neither smoking nor menopause were associated with differences in any of the measures. We also evaluated the effects of sex hormone usage and found that neither oral contraceptives (13a121 premenopausal women were using oral contraceptives) nor hormone replacement therapy (11a62 postmenopausal women were undergoing therapy) affected LDL size properties (data not shown). Therefore, only gender and diabetes status were included in subsequent models, in addition to age.
Relationship between measures of LDL size and adiposity LDL patterns were dichotomized at 26.2 nm into those having small or large LDLs. Analysis of variance showed that persons with the small LDL phenotype tended to be more obese than those with the large LDL phenotype, but this trend was signi®cant only for BMI (Table 3) . Table 4 gives the partial correlation coef®cients from regression analyses for the Levels of signi®cant difference: * P`0.05; **P`0.01; ***P`0.001. (Table 4) . We used stepwise regression analyses to select the adiposity measure(s) independently correlated with the measures of LDL size. Table 5 lists the signi®cant correlates of the LDL size indicators. For each case in which an adiposity measure was selected for the ®nal model, the strongest correlate was WHR. In fact, for median diameter and LDL-II, WHR was the ®rst (or only) variable to enter the model.
Correlation of WHR and BMI with size distributions of LDL-C
To further explore the LDL particle size ranges that are correlated with adiposity measures, we converted fractional absorbance pro®les into pro®les of cholesterol concentration from 23±29 nm at 0.1 nm increments of particle diameter. We evaluated separately the correlations of WHR and BMI with each size increment of particles; for consistency, all multiple regression models included gender, age and diabetes. Given in Figure 3 are the average absorbance pro®les for LDL-C (Panel A) and the partial correlation coef®cients for WHR and BMI derived from separate regression analyses (Panel B). When examined at the level of 0.1 nm increments of particle diameter, we found that the two measures of adiposity gave different patterns of correlation with LDL size particles: WHR showed a signi®cant positive correlation with LDLs between 25.9±26.3 nm in the LDL-II region, whereas, BMI showed a signi®cant negative correlation with LDLs between 27.3±28.1 nm in the LDL-I region.
To visualize better the overall differences in LDL pro®le for individuals contrasting in BMI and WHR, we divided the population into thirds according to BMI or WHR. Figure 4 gives the average LDL pro®les for the upper and lower thirds for BMI (upper panel) and for WHR (lower panel). The ®gure also indicates the regions of signi®cant differences between the contrast groups: 27.2±28.2 nm for BMI and 26.0±26.2 nm for WHR.
Relationship with TG Table 6 gives the partial correlation coef®cients of TG with measures of adiposity and LDL size. TG was positively correlated with all measures of adiposity and WHR was the strongest correlate. TG and LDL size measures were also strongly correlated. We found that including TG in the multiple regression model BMI body-mass index; WHR waist-to-hip ratio; STR subscapular-triceps skinfold ratio. WHR waist-to-hip ratio; BMI body-mass index.
LDL particle size and adiposity DL Rainwater et al abolished any signi®cant correlations previously observed for the measures of LDL size and adiposity (data not shown).
Discussion
LDL particle size is strongly related to risk of CVD. In this study, we determined LDL size phenotypes using nondenaturing gradient gel electrophoresis, as previously described. 26, 31 This method is highly repeatable and it enables excellent resolution of LDL particles. We devised three different measures of LDL size properties, which were analyzed for correlations with adiposity. (1) We measured peak particle diameter (LDL size); (2) We measured median diameter, which represents an attempt to summarize the LDL size distribution into a single continuous variable and is quite similar to the LDL particle score used in other laboratories. 18, 35 The advantage of calculating median diameter, however, is that it does not require making decisions about the existence of underlying peaks and their relative amounts; and (3) Finally, we estimated the amount of cholesterol in speci®c LDL subfractions. Without a direct measurement of LDL-C, we used a modi®cation of the Friedewald formula to calculate LDL-C, based Panel A shows the average pro®le for LDL-C separated by gradient gel electrophoresis for all subjects in the study. The shape of the average pro®le re¯ects the proportional distribution of predominant peak diameters for these subjects. Panel B shows the partial correlations for the waist-to-hip ratio (WHR, triangles) and for the body-mass index (BMI, squares) derived from separate multiple regression analyses of WHR or BMI with LDL-C in each fraction (models also included gender, age and diabetes status). The dashed lines indicate the partial correlation coef®cients for P 0.05. Figure 4 Average low-density lipoprotein cholesterol (LDL-C) pro®les (0.1 mm increments) of nondiabetic subjects in the upper and lower thirds of the body-mass index (BMI, upper panel) and waist-to-hip ratio (WHR, lower panel). LDL-C pro®les from 81 subjects in each group were averaged for this analysis. A signi®cant difference for a fraction was indicated* if the mean AE 2 s.e.m. for the upper third did not overlap with the mean AE 2 s.e.m. for the lower third. BMI body-mass index; WHR waist-to-hip ratio; STR subscapular-triceps skinfold ratio.
LDL particle size and adiposity DL Rainwater et al on cholesterol in apoB-containing lipoproteins and TG concentrations. The calculated values are accurate for up to 8 mmolaL TG, 33, 34 and this required excluding two samples with higher TG concentrations.
A frequency histogram of LDL particle size ( Figure  1A) showed a marked bimodality that appeared to be more striking than previously reported in primarily non-Hispanic white populations. 3, 4, 36, 37 However, the nadir at about 26.2 nm is near the upper boundary for pattern B plus I (intermediate) size LDLs 38 and, therefore, particles on the boundary were somewhat larger than would be expected for non-Hispanic whites. Despite using standards that were commercially available or were calibrated externally, 26 it is possible that slight calibration differences could account for our ®nding of a larger cutpoint. It is also possible that the larger cutpoint is a unique characteristic of this population of Mexican-Americans, possibly stemming from genetic differences between Mexican-Americans and non-Hispanic whites in prevalence of obesity, diabetes, dyslipidaemia, etc. Alternatively, the differences could re¯ect environmental in¯uences that tend to shift LDLs to larger sizes. For example, data from the San Antonio Heart Study suggest that Mexican-Americans tended to consume a more atherogenic diet than non-Hispanic whites from the same neighborhoods. 39 On the basis of dietary recall instruments, 21 the Mexican-American subjects in the present study consumed an average of 2907AE 90 calories and 470AE 17 mg cholesterol per day; 31.9 AE 0.3% of calories were from fat and 36.9AE 0.2% of fat calories were from saturated fat (data not shown). It is possible that this relatively fatenriched diet increased the size boundary between small and large LDLs in this population. Regardless of the reason(s) for differences with other studies, it is important to recognize that the size measures are internally consistent.
Based on the de®nite bimodal pattern of LDL size, we considered particles in this study that were smaller than 26.2 nm in diameter to be small LDLs. Some (but not all) of these small LDLs might be classi®ed as I (intermediate) or even A pattern LDLs in other studies. 38 Therefore, it is possible that small LDLs in Mexican-Americans might not be as atherogenic as in other populations. However, it is likely that relative atherogenicity of LDLs is graded rather than being dichotomized. For example, LDL susceptibility to oxidation, was graded across a continuum of particle sizes. 40 Therefore, within this population of MexicanAmericans, those with relatively smaller LDLs are likely to be at greater risk of CVD than those with relatively larger LDL phenotypes.
As might be expected from the relatively higher boundary between large and small LDLs, the average LDL absorbance pro®le was also shifted towards larger particles compared to the report of Williams and Krauss. 19 For example, they reported the average LDL size to be 26.05 nm for men, 26.22 nm for premenopausal women and 26.09 nm for postmenopausal women, 19 whereas average median LDL diameter in Mexican-Americans was 26.43 nm. In part, this shift might be explained by the fact that Williams and Krauss measured protein (apoB) while we measured cholesterol distributions. Because larger LDLs are cholesterol-rich and protein-poor, and smaller LDLs are cholesterol-poor and protein-rich, it is clear that a protein stain will tend to be shifted towards smaller particle sizes compared to a cholesterol stain. Supporting this interpretation are data from the Framingham study, which reported mean particle score for women to be 2.42 nm (that is, b 26.6 nm) 41 and 3.33 nm (that is, 26.0±26.6 nm) for men. 35 These data are very similar to the average median diameters of 26.6 nm and 26.2 nm for women and men, respectively, in this study (data not shown).
We found several important correlates of LDL size phenotype measures, including gender and diabetes status, which were independently associated with LDL size. In general, we found higher proportions of small dense LDLs in men and in diabetic subjects. Of nondiabetic women and men, 25% and 49%, respectively, and of diabetic women and men, 40% and 80%, respectively, had small LDLs (that is, LDLs smaller than 26.2 nm), as illustrated in Figure 2 . Thus, we included gender and diabetes in each model. Various parameters of reproductive history (for example, oral contraceptive use, menopause and estrogen replacement therapy) have been reported in other studies to be associated with LDL particle size phenotypes, 19 ,42 ± 47 although we did not detect significant effects of these covariates in this populationbased study. The lack of a signi®cant association between reproductive hormones and LDL particle size may be related to unique characteristics of Mexican-Americans, but it is more likely that it is due to the relatively small numbers of individuals in the various categories (that is, this study was not speci®cally designed to evaluate these covariate effects).
For this study, we selected ®ve measures of adiposity: BMI, FM, WHR, waist circumference and STR. These different measures are by no means independent of each other. Several studies indicate they are signi®cantly correlated, both phenotypically and genetically, 48, 49 and the data in this study con®rm this inter-relatedness. Nevertheless, the measures also appear to re¯ect different aspects of body fat composition, which may have different physiological consequences. 6, 50 All obesity measures, except FM, were correlated with one or more LDL size phenotype measures. Although signi®cant, the correlations were of small magnitude (for example, the highest correlation, that for LDL-II cholesterol and waist circumference, explained only 3.2% of the variance). The obesity indices were negatively correlated with LDL size and median diameter, implying that obesity is associated with smaller LDLs, even after adjustment for gender and diabetes.
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Among the various adiposity measures, WHR was the strongest correlate of LDL size phenotypes, in agreement with several previous studies. 16, 17 Because WHR is frequently interpreted to indicate deposition of visceral fat, 9 this ®nding suggests a signi®cant relationship between visceral adiposity and LDL size phenotypes. Waist circumference also re¯ects visceral adiposity and may actually be a better indicator than WHR. 24 However, waist circumference was not as strong a predictor of LDL size variation as WHR. In this study, waist circumference was more strongly correlated with general body fatness than WHR (that is, correlation coef®cients for BMI and FM with waist circumference were 0.80 and 0.75, respectively, while their correlations with WHR were 0.27 and 0.17, respectively; D.L. Rainwater, unpublished observations). These observations suggest that the waist circumference measurement may re¯ect both visceral adiposity and general body fatness in this population. In any event, the present data suggest WHR is the better measure for the aspect of obesity that is associated with elevated TG concentration and smaller LDL particle size in Mexican-Americans.
The most consistent relationship of the body fat indices with LDL size phenotype was a positive correlation with small LDLs in the LDL-II subfraction (25.5±26.4 nm). This observation differs with that of Williams and Krauss 19 who reported (only in men) that the strongest correlate of BMI was the LDL-III subfraction (24.2±25.5 nm). There are several possible reasons to explain the difference (discussed above), but it should be noted that in both cases the positive correlation was with smaller LDLs as de®ned in each population. We explored the precise range of particle diameters that are associated with adiposity measures and found that WHR was positively correlated with smaller LDLs of approximately 26 nm in diameter (25.9±26.3 nm) occurring in the LDL-II subfraction, and showed a nonsigni®cant trend for negative relationship with larger LDLs. In contrast, BMI showed a nonsigni®cant trend for positive correlation with 26 nm particles and a signi®cant negative correlation with larger particles (27.3±28.1 nm) occurring in the LDL-I subfraction. Probably because of the broad range of particle sizes included in LDL-I, this signi®cant negative correlation was not detected when the subfraction was considered as a whole. Thus, the data are consistent with both BMI and WHR being inversely associated with LDL size distribution. Further research will be necessary to determine if the different patterns of LDL size association for BMI and WHR result from differences in the aspect(s) of adiposity re¯ected in these two measures.
Also associated with visceral adiposity is increased TG concentrations. 9 When plasma TG concentrations were included in the models, then no adiposity measure was signi®cantly correlated with any LDL size measure, suggesting that the association between LDL particle size and adiposity may be mediated by effects on TG metabolism. Supporting this interpretation is the fact that WHR was also the strongest correlate of TG in this study population.
Conclusion
Thus, the present data for Mexican-Americans support the notion that increasing adiposity (particularly visceral adiposity) is signi®cantly associated with increasing incidence of small dense LDL particles which, in other populations, are a component of the atherogenic lipoprotein phenotype. This relationship may be mediated by changes in TG metabolism and may help explain the surplus of CVD often observed with visceral obesity.
